Alastair J. O'brien

Gower Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Non-selective beta-blockers in cirrhosis and AKI: Time to reconsider routine withdrawal?

Non-selective beta-blockers in cirrhosis and AKI: Time to reconsider routine withdrawal?

Journal: Journal of hepatology

Published: August 05, 2026

Serum SOS1 as a prognostic biomarker and therapeutic target for progressive liver disease.

Serum SOS1 as a prognostic biomarker and therapeutic target for progressive liver disease.

Journal: iScience

Published: January 24, 2026

Segmenting Increasing- and High-Risk Alcohol Drinkers by Motives and Occasions: Implications for Targeted Interventions.

Segmenting Increasing- and High-Risk Alcohol Drinkers by Motives and Occasions: Implications for Targeted Interventions.

Journal: Nutrients

Published: October 30, 2025

A systematic review and meta-analysis of the use of human albumin solution for treating the complications of liver cirrhosis.

A systematic review and meta-analysis of the use of human albumin solution for treating the complications of liver cirrhosis.

Journal: Hepatology communications

Published: October 13, 2025

Correction: Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study).

Correction: Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study).

Journal: Trials

Published: August 07, 2025

Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial.

Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial.

Journal: Annals of hepatology

Published: July 25, 2025

Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRE.

Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRE.

Journal: Annals of hepatology

Published: February 21, 2025

Long-term albumin treatment for decompensated cirrhosis in Italy: A propensity score-matched, retrospective, real-world chart analysis.

Long-term albumin treatment for decompensated cirrhosis in Italy: A propensity score-matched, retrospective, real-world chart analysis.

Journal: Annals of hepatology

Published: January 24, 2025

Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study).

Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study).

Journal: Trials

Published: January 15, 2025

Changing the Dial on Pathogen Detection in SBP.

Changing the Dial on Pathogen Detection in SBP.

Journal: Journal of clinical and experimental hepatology

Published: August 19, 2024

Hyperbilirubinemia at hospitalization predicts nosocomial infection in decompensated cirrhosis: Data from ATTIRE trial.

Hyperbilirubinemia at hospitalization predicts nosocomial infection in decompensated cirrhosis: Data from ATTIRE trial.

Journal: Hepatology communications

Published: June 13, 2024

Cirrhosis in over 16s: assessment and management-updated summary of NICE guidance.

Cirrhosis in over 16s: assessment and management-updated summary of NICE guidance.

Journal: BMJ (Clinical research ed.)

Published: November 22, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026